Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo

Journal of Leukocyte Biology

Volumn 85, Issue 5, 2009, Pages 788-795

  Klaschik, Sven ^a   Tross, Debra ^a   Klinman, Dennis M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gene regulation; Molecular biology; Rodent; Signal transduction

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 9; STAT1 PROTEIN; STAT2 PROTEIN; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR SF10; UNCLASSIFIED DRUG; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE; TLR9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE INTERACTION; HOST RESISTANCE; IMMUNOSTIMULATION; INNATE IMMUNITY; KNOCKOUT MOUSE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPLEEN; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOLOGY; C57BL MOUSE; CPG ISLAND; DNA MICROARRAY; DRUG EFFECT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METABOLISM; MOUSE MUTANT;

BACTERIA (MICROORGANISMS); MUS; RODENTIA;

ANIMALS; COMPUTATIONAL BIOLOGY; CPG ISLANDS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPLEEN; TOLL-LIKE RECEPTOR 9;

EID: 65549140232     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1008671     Document Type: Article

References (51)

1. Klinman, D. M., Yi, A., Beaucage, S. L., Conover, J., Krieg, A. M. (1996) CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFNγ. Proc. Natl. Acad. Sci. USA 93, 2879-2883. (Pubitemid 26116242)
2. Sun, S., Zhang, X., Tough, D. F., Sprent, J. (1998) Type I interferonmediated stimulation of T cells by CpG DNA. J. Exp. Med. 188, 2335-2342. (Pubitemid 29028505)
3. Stacey, K. J., Sweet, M. J., Hume, D. A. (1996) Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157, 2116-2120.
4. Ballas, Z. K., Rasmussen, W. L., Krieg, A. M. (1996) Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157, 1840-1847.
5. Broide, D., Schwarze, J., Tighe, H., Gifford, T., Nguyen, M. D., Malek, S., Van Uden, J., Martin, E., Gelfand, E. W., Raz, E. (1998) Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161, 7054-7062. (Pubitemid 28562256)
6. Sparwasser, T., Miethke, T., Lipford, G., Erdmann, A., Hacker, H., Heeg, K., Wagner, H. (1997) Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-α-mediated shock. Eur. J. Immunol. 27, 1671-1679. (Pubitemid 27302848)
7. Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A., Raz, E. (1997) Immunostimulatory DNA sequences function as T helper-1 promoting adjuvants. Nat. Med. 3, 849-854. (Pubitemid 27353443)
8. Akira, S., Takeda, K., Kaisho, T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680. (Pubitemid 32747155)
9. Akira, S., Takeda, K. (2004) Toll-like receptor signaling. Nat. Rev. Immunol. 4, 499-511.
10. Hacker, H., Vabulas, R. M., Takeuchi, O., Hoshino, K., Akira, S., Wagner, H. (2000) Immune cell activation by bacterial CpG-DNA through myeroid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med. 192, 595-600. (Pubitemid 30666261)
11. Aderem, A., Ulevitch, R. J. (2000) Toll-like receptors in the induction of the innate immune response. Nature 406, 782-787. (Pubitemid 30671237)
12. Bauer, S., Kirschning, C. J., Hacker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., Lipford, G. B. (2001) Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98, 9237-9242. (Pubitemid 32743900)
13. Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C., Monks, B. G., McKnight, C. J., Lamphier, M. S., Duprex, W. P., Espevik, T., Golenbock, D. T. (2007) Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat. Immunol. 8, 772-779. (Pubitemid 46965353)
14. Gao, J. J., Diesl, V., Wittmann, T., Morrison, D. C., Ryan, J. L., Vogel, S. N., Follettie, M. T. (2002) Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide. J. Leukoc. Biol. 72, 1234-1245. (Pubitemid 36008895)
15. Schmitz, F., Mages, J., Heit, A., Lang, R., Wagner, H. (2004) Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling. Eur. J. Immunol. 34, 2863-2873. (Pubitemid 39430162)
16. Kato, A., Homma, T., Batchelor, J., Hashimoto, N., Imai, S., Wakiguchi, H., Saito, H., Matsumoto, K. (2003) Interferon-α/β receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC Immunol. 4, 8. (Pubitemid 38692927)
17. Klaschik, S., Gursel, I., Klinman, D. M. (2007) CpG-mediated changes in gene expression in murine spleen cells identified by microarray analysis. Mol. Immunol. 44, 1095-1104. (Pubitemid 44415981)
18. Takeshita, S., Takeshita, F., Haddad, D. E., Ishii, K. J., Klinman, D. M. (2000) CpG oligodeoxynucleotides induce murine macrophages to upregulate chemokine mRNA expression. Cell. Immunol. 206, 101-106. (Pubitemid 32121622)
19. Ishii, K. J., Takeshita, F., Gursel, I., Gursel, M., Conover, J., Nussenzweig, A., Klinman, D. M. (2002) Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation. J. Exp. Med. 196, 269-274. (Pubitemid 34787517)
20. Zelenay, S., Elias, F., Flo, J. (2003) Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides. Eur. J. Immunol. 33, 1382-1392. (Pubitemid 36609157)
21. Datta, N., Mukherjee, S., Das, L., Das, P. K. (2003) Targeting of immunostimulatory DNA cures experimental visceral Leishmaniasis through nitric oxide up-regulation and T cell activation. Eur. J. Immunol. 33, 1508-1518. (Pubitemid 36790411)
22. Ito, S., Ishii, K. J., Gursel, M., Shirotra, H., Ihata, A., Klinman, D. M. (2005) CpG oligodeoxynucleotides enhance neonatal resistance to Listeria infection. J. Immunol. 174, 777-782. (Pubitemid 40094272)
23. Yang, Y. H., Dudoit, S., Luu, P., Lin, D. M., Peng, V., Ngai, J., Speed, T. P. (2002) Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15.
24. Calvano, S. E., Xiao, W., Richards, D. R., Felciano, R. M., Baker, H. V., Cho, R. J., Chen, R. O., Brownstein, B. H., Cobb, J. P., Tschoeke, S. K., Miller-Graziano, C., Moldawer, L. L,, Mindrinos, M. N., Davis R.W., Tompkins, R.G., Lowry, S. F.; Inflamm and Host Response to Injury Large Scale Collab. Res. Program (2005) A network-based analysis of systemic inflammation in humans. Nature 437, 1032-1037.
25. Wright, G. W., Simon, R. M. (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19, 2448-2455.
26. Shen, J., Reis, J., Morrison, D. C., Papasian, C., Raghavakaimal, S., Kolbert, C., Qureshi, A. A., Vogel, S. N., Qureshi, N. (2006) Key inflammatory signaling pathways are regulated by the proteasome. Shock 25, 472-484. (Pubitemid 43755918)
27. Bowick, G. C., Fennewald, S. M., Elsom, B. L., Aronson, J. F., Luxon, B. A., Gorenstein, D. G., Herzog, N. K. (2006) Differential signaling networks induced by mild and lethal hemorrhagic fever virus infections. J. Virol. 80, 10248-10252.
28. Kumar, D., Srikanth, R., Ahlfors, H., Lahesmaa, R., Rao, K. V. (2007) Capturing cell-fate decisions from the molecular signatures of a receptor-dependent signaling response. Mol. Syst. Biol. 3, 150. (Pubitemid 350223360)
29. Jahrsdorfer, B., Weiner, G. J. (2003) CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy. Curr. Opin. Investig. Drugs 4, 686-690. (Pubitemid 36916708)
30. Carpentier, A. F., Auf, G., Delattre, J. Y. (2003) CpG-oligonucleotides for cancer immunotherapy: review of the literature and potential applications in malignant glioma. Front. Biosci. 8, e115-e127. (Pubitemid 38918578)
31. Ashkar, A. A., Bauer, S., Mitchell, W. J., Vieira, J., Rosenthal, K. L. (2003) Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J. Virol. 77, 8948-8956. (Pubitemid 36936104)
32. Krieg, A. M., Homan, L. L., Yi, A. K., Harty, J. T. (1998) CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161, 2428-2434.
33. Walker, P. S., Scharton-Kersten, T., Krieg, A. M., Love-Homan, L., Rowton, E. D., Udey, M. C., Vogel, J. C. (1999) Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for Leishmaniasis via IL-12 and IFNγ dependent mechanisms. Proc. Natl. Acad. Sci. USA 96, 6970-6975. (Pubitemid 29274994)
34. Zimmermann, S., Egeter, O., Hausmann, S., Lipford, G. B., Rocken, M., Wagner, H., Heeg, K. (1998) CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine Leishmaniasis. J. Immunol. 160, 3627-3630. (Pubitemid 28176060)
35. Krieg, A. M. (2007) Development of TLR9 agonists for cancer therapy 8. J. Clin. Invest. 117, 1184-1194. (Pubitemid 46718403)
36. Weighardt, H., Feterowski, C., Veit, M., Rump, M., Wagner, H., Holzmann, B. (2000) Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J. Immunol. 165, 4537-4543. (Pubitemid 30795833)
37. Dong, L., Mori, I., Hossain, M. J., Liu, B., Kimura, Y. (2003) An immunostimulatory oligodeoxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response. J. Gen. Virol. 84, 1623-1628. (Pubitemid 36675534)
38. Heckelsmiller, K., Rall, K., Beck, S., Schlamp, A., Seiderer, J., Jahrsdorfer, B., Krug, A., Rothenfusser, S., Endres, S., Hartmann, G. (2002) Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model. J. Immunol. 169, 3892-3899.
39. Horner, A. A., Raz, E. (2002) Immunostimulatory sequence oligodeoxynucleotide- based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases. J. Allergy Clin. Immunol. 110, 706-712.
40. Halperin, S. A., Van Nest, G., Smith, B., Abtahi, S., Whiley, H., Eiden, J. J. (2003) A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant. Vaccine 21, 2461-2467. (Pubitemid 36561337)
41. Leonard, J. P., Link, B. K., Emmanouilides, C., Gregory, S. A., Weisdorf, D., Andrey, J., Hainsworth, J., Sparano, J. A., Tsai, D. E., Horning, S., Krieg, A. M., Weiner, G. J. (2007) Phase I trial of Toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma. Clin. Cancer Res. 13, 6168-6174. (Pubitemid 350075077)
42. Jahrsdorfer, B., Muhlenhoff, L., Blackwell, S. E., Wagner, M., Poeck, H., Hartmann, E., Jox, R., Giese, T., Emmerich, B., Endres, S., Weiner, G. J., Hartmann, G. (2005) B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides. Clin. Cancer Res. 11, 1490-1499. (Pubitemid 40315231)
43. Hegele, A., Dalpke, A., Heeg, K., Barth, P., Varga, Z., Hofmann, R., Olbert, P. (2005) Immunostimulatory CpG oligonucleotides reduce tumor burden after intravesical administration in an orthotopic murine bladder cancer model. Tumour Biol. 26, 274-280. (Pubitemid 41243228)
44. Hemmi, H., Takeuchi, O., Kawai, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., Akira, S. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745. (Pubitemid 32015992)
45. Takeshita, F., Leifer, C. A., Gursel, I., Ishii, K., Takeshita, S., Gursel, M., Klinman, D. M. (2001) Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167, 3555-3558. (Pubitemid 32910795)
46. Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., Akira, S. (2002) Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Tolllike receptor signaling. J. Immunol. 169, 6668-6672. (Pubitemid 36899248)
47. Yamamoto, S., Yamamoto, T., Katoaka, T., Kuramoto, E., Yano, O., Tokunaga, T. (1992) Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 148, 4072-4076.
48. Krieg, A. M., Yi, A., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., Klinman, D. M. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-548.
49. Halpern, M. D., Kurlander, R. J., Pisetsky, D. S. (1996) Bacterial DNA induces murine interferon-γ production by stimulation of IL-12 and tumor necrosis factor-α. Cell. Immunol. 167, 72-78. (Pubitemid 26048848)
50. Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., Klinman, D. M. (1999) Bacterial DNA containing CpG motifs stimulates lymphocyte- dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162, 2291-2298. (Pubitemid 29288853)
51. Bajenoff, M., Egen, J. G., Qi, H., Huang, A. Y., Castellino, F., Germain, R. N. (2007) Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node. Trends Immunol. 28, 346-352. (Pubitemid 47077926)